Biogen Closes The Book On The Aduhelm Saga

 
• By Jessica Merrill
  
closed book
Biogen is ending development and commercialization of Aduhelm • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Post-Marketing Regulation & Studies

More from Product Reviews